Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
158 USD | +0.03% |
|
-1.69% | +63.85% |
26/06 | Monetary policy is getting even more confusing | ![]() |
26/06 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.85% | 1.49TCr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+4.49% | 1.39TCr | |
+116.20% | 1.08TCr |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172